Show simple item record

dc.contributor.authorMurueta-Goyena Larrañaga, Ane
dc.contributor.authorAndikoetxea, Ane
dc.contributor.authorGómez Esteban, Juan Carlos
dc.contributor.authorGabilondo Cuellar, Iñigo
dc.date.accessioned2020-02-25T09:29:05Z
dc.date.available2020-02-25T09:29:05Z
dc.date.issued2019-10-30
dc.identifier.citationFrontiers in Pharmacology 10 : (2019) // Article ID 1294es_ES
dc.identifier.issn1663-9812
dc.identifier.urihttp://hdl.handle.net/10810/41432
dc.description.abstractNon-motor symptoms are common in Parkinson's disease (PD) and they represent a major source of disease burden. Several non-motor manifestations, such as rapid eye movement sleep behavior disorder, olfactory loss, gastrointestinal abnormalities, visual alterations, cognitive and mood disorders, are known to precede the onset of motor signs. Nonetheless, the mechanisms mediating these alterations are poorly understood and probably involve several neurotransmitter systems. The dysregulation of GABAergic system has received little attention in PD, although the spectrum of non-motor symptoms might be linked to this pathway. This Mini Review aims to provide up-to-date information about the involvement of the GABAergic system for explaining non-motor manifestations in early stages of PD. Therefore, special attention is paid to the clinical data derived from patients with isolated REM sleep behavior disorder or drug-naive patients with PD, as they represent prodromal and early stages of the disease, respectively. This, in combination with animal studies, might help us to understand how the disturbance of the GABAergic system is related to non-motor manifestations of PD.es_ES
dc.description.sponsorshipThis study was partially funded by the Michael J. Fox Foundation (2014 Rapid Response Innovation Awards; Grant 10189), the Carlos III Health Institute through Projects PI14/00679 and PI16/00005, and a Juan Rodes Grant (JR15/00008) (I.G.) (cofunded by the "Investing in Your Future" European Regional Development Fund/European Social Fund programme), the Department of Health of the Basque Government through Project 2016111009, and EITB/BIOEF telemarathon for Neurodegenerative Diseases (BIO17/ND/010/BC).es_ES
dc.language.isoenges_ES
dc.publisherFrontiers Mediaes_ES
dc.rightsinfo:eu-repo/semantics/openAccesses_ES
dc.rights.urihttp://creativecommons.org/licenses/by/3.0/es/*
dc.subjectGABAes_ES
dc.subjectREM sleep behavior disorderes_ES
dc.subjecthyposmiaes_ES
dc.subjectvisual alterationses_ES
dc.subjectgastrointestinal symptomses_ES
dc.subjectneurotransmitterses_ES
dc.subjectsleep behavior disorderes_ES
dc.subjectmessenger-rna expressiones_ES
dc.subjectolfactory dysfunctiones_ES
dc.subjectcognitive impairmentes_ES
dc.subjectpresynaptic inhibitiones_ES
dc.subjectprefrontal cortexes_ES
dc.subjectbasal gangliaes_ES
dc.subjectearly markeres_ES
dc.subjectbulbes_ES
dc.titleContribution of the GABAergic System to Non-Motor Manifestations in Premotor and Early Stages of Parkinson’s Diseasees_ES
dc.typeinfo:eu-repo/semantics/articlees_ES
dc.rights.holder2019 Murueta-Goyena, Andikoetxea, Gómez-Esteban and Gabilondo. This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.es_ES
dc.rights.holderAtribución 3.0 España*
dc.relation.publisherversionhttps://www.frontiersin.org/articles/10.3389/fphar.2019.01294/fulles_ES
dc.identifier.doi10.3389/fphar.2019.01294
dc.departamentoesNeurocienciases_ES
dc.departamentoeuNeurozientziakes_ES


Files in this item

Thumbnail
Thumbnail

This item appears in the following Collection(s)

Show simple item record

2019 Murueta-Goyena, Andikoetxea, Gómez-Esteban and Gabilondo. This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.
Except where otherwise noted, this item's license is described as 2019 Murueta-Goyena, Andikoetxea, Gómez-Esteban and Gabilondo. This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.